Drug reference

jnj-78436735/ad26.cov2.s

adenovirus vaccine · vaccine

adenovirus vaccinevaccine

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

JNJ-78436735/Ad26.COV2.S contains a safe adenovirus vector with dsDNA encoding the SARS-CoV-2 spike protein, stimulating an immune response for COVID-19 prevention.

Indications

prevention of severe or fatal COVID-19

Dosing

Adult: injected as a single dose

Related guidelines

Stroke and TIA — secondary prevention

AHA · Neurology · 2021

Tobacco-related cancer prevention

ICMR · Oncology · 2021

Cardiovascular disease prevention

ESC · Cardiology · 2021

Primary prevention of cardiovascular disease

AHA · Cardiology · 2019

Infective endocarditis prevention

ADA_DENTAL · Dentistry · 2015

Other adenovirus vaccine drugs

chadox1/azd1222

0 brands

sputnik v/gam-covid-vac

0 brands

Ask House about jnj-78436735/ad26.cov2.s

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team